Multiplex testing in high risk BRCA1/2-negative families.

被引：0
|
作者：
Esteban, Irene
Bonache, Sandra
Gadea, Neus
Tenes, Ana
Carrasco, Estela
Balmana, Judith
Gutierrez-Enriquez, Sara
Diez, Orland
机构：
[1] Vall dHebron Inst Oncol, Barcelona, Spain
[2] Vall dHebron Inst Oncol, Oncogenet Grp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Med Oncol, Breast Canc Unit, Barcelona, Spain
[4] Vall dHebron Inst Reserca, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Oncogenet Grp, E-08193 Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e12557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12557
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.
    Hauke, Jan
    Heimbach, Andre
    Richters, Lisa Katharina
    Kroeber, Sandra
    Altmuller, Janine
    Thiele, Holger
    Nuernberg, Peter
    Wappenschmidt, Barbara
    Neidhardt, Guido
    Rhiem, Kerstin
    Schmutzler, Rita K.
    Hahnen, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families
    Rodríguez-López, R
    Osorio, A
    Sánchez-Pulido, L
    De la Hoya, M
    Barroso, A
    Caldés, T
    Benítez, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 136 - 137
  • [3] The psychosocial impact of genetic testing on members of BRCA1/2 positive families.
    Sheridan, G
    Scanlan, N
    Horler, A
    Nanda, S
    Jung, JH
    Ainsworth, PJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 359 - 359
  • [4] Analysis of BRCA1 in high-risk breast and ovarian cancer families.
    Rohlfs, EM
    Yang, Q
    Skrzynia, C
    Graham, ML
    Liu, ET
    Silverman, LM
    [J]. CLINICAL CHEMISTRY, 1997, 43 : 775 - 775
  • [5] Addressing the needs of men in BRCA1/2 families.
    Daly, M. B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S98 - S98
  • [6] Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families.
    Schmutzler, R
    Schwarz-Boeger, U
    Bastert, G
    Deininger, J
    Hahn, W
    Kast, K
    Prieshof, B
    Volm, T
    Kiechle, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 889S - 889S
  • [7] Outcome of BRCA1 and BRCA2 testing in 89 Dutch breast/ovarian cancer families.
    Gille, JJP
    Strunk, MHP
    van Schooten, RJ
    Zweemer, RP
    Verheijen, RHM
    Menko, FH
    Pals, G
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A66 - A66
  • [8] BRCA1 and BRCA2 mutation screening in breast cancer families.
    Phelan, CM
    Lancaster, JM
    Gumbs, C
    de los Rios, P
    Abrahamson, J
    Warner, E
    Parfrey, NA
    Futreal, PA
    Narod, SA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 12 - 12
  • [9] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families.
    Schwarz-Boeger, U
    Schmutzler, RK
    Bastert, G
    Bender, HG
    Beckmann, MW
    Caffier, H
    Crohns, C
    Deininger, J
    Dietl, J
    Ditsch, N
    Distler, W
    Estevez-Schwarz, L
    Hepp, H
    Herroeder, N
    Huebbel, V
    Huettner, C
    Jackisch, C
    Jonat, W
    Kandel, M
    Kast, K
    Kaufmann, M
    Krapfl-Gast, AS
    Kreienberg, R
    Kuschel, B
    Kuschel, B
    Luck, H
    Meindl, A
    von Minckwitz, G
    Nestle-Kraemling, C
    Paepke, S
    Prieshof, B
    Rensing, K
    Rhiem, KA
    Schaeffer, MA
    Straub, L
    Untch, M
    Kiechle, T
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S155
  • [10] Mutation analysis of the BRCA1-interacting genes ZBRK1 and BRIP1 among BRCA1/2-negative probands from breast/ovarian cancer families.
    Struewing, JP
    Rutter, JL
    Dávila, MR
    Smith, AM
    Greene, MH
    Tucker, MA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 393 - 393
12345